Home » Headlines » Currently Reading:

Morning Headlines 2/20/17

February 19, 2017 Headlines 4 Comments

Opening Keynote: The Art of Deception: How Hackers and Con Artists Manipulate You and What You Can Do About It

HIMSS17 kicks off as white coat hacker Kevin Mitnick takes the stage to discuss emerging cybersecurity threats and how to detect and defend against them.

Touted IBM supercomputer project at MD Anderson on hold after audit finds spending issues

Auditors find that MD Anderson Cancer Center’s now stalled effort to employ IBM Watson in the fight against cancer was paid for with funds that were secured by hospital executives that intentionally sidestepped purchasing rules.

$5.5 million HIPAA settlement shines light on the importance of audit controls

Memorial Healthcare Systems (FL) pays $5.5 million to settle HIPAA violations after discovering that a former employee continued to use his login credentials to access more than 80,000 patient records without permission.

Forbes World’s Most Admired Companies

Cerner, CVS Health, St. Jude Medical Abbott Laboratories, and Aetna are named to Forbes Most Admired Companies list.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there are "4 comments" on this Article:

  1. RE: MD Anderson & IBM Watson – Another $60M out the door for another IT project, this time IBM Watson…comes on the heels of a $405M drop in net income attributed to Epic. A publicly available audit report says Watson couldn’t work with Epic. Maybe Epic isn’t as ‘Open’ as Judy claims.

  2. The University of Texas audit is instructive. File this one under Innovation Management 101. The IBM Watson project is highly experimental and should not be governed like a traditional project. Risks should have been clearly articulated upfront. Kudos for an attempt to break new ground. Always expect set backs, that’s what innovation is all about. However, is MD Anderson the only party at risk ($$$$)? The onus is on MD Anderson to broker a win-win deal. Did the others have skin in the game, or did they just sell a bunch of h/w, s/w and services like a traditional project? Someone made quota on this deal, but to what end? Dream big, but plan SMALL.

  3. RE — Watson & Nant: Not a great two weeks for the leading Cancer Moonshot vendors. Last week Slate takes apart Nant Health, this week Forbes finds that IBM is completely ineffective at MD Anderson and being scrapped after a $60M investment, with MD Anderson going back to bid. Sounds like vaporware working at its best.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Mr. HIStalk: Probably about the same. Amazon didn't offer to let me try the Moto G for one visit and then change if I didn't like it ...
  • ex-HHC: re: Moto G plus. How does the amount of time you spent researching your new phone compare to the amount you put into cho...
  • P. RN: Re: Expired Mallow Cup's post - I couldn't agree more. Building/entering order-sets requires critical thinking. There m...
  • Mobile Man: The "problem" is the "business"... It's the way we pay for healthcare. Everything evolves around that in the "commerci...
  • Income Needer: @ Silence Dogwood: Are you saying that Population Health is not selling? Overall and not limited to Cardigm, I thoug...

Sponsor Quick Links